5% Topical Ibuprofen (IBU) for Ankle Sprai

• Conditions: First or second degree ankle sprain; Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]

• Registration Number: EUCTR2015-001874-16-Outside-EU/EEA
• Lead Sponsor: Pfizer

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-07-29
• Last Update Posted: 4 August 2015

Recruitment & Eligibility

• Status: A
• Sex: All
• Target Recruitment: 304

Inclusion Criteria

- First or second degree ankle sprain within 48 hours of first dose of study medication
- Medically cleared to participate

Are the trial subjects under 18? yes
Number of subjects for this age range: 150
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 100
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 54

Exclusion Criteria

- Similar injury of same joint within last 6 months
- Requires bed rest, surgery, or over-the-counter or prescription analgesics

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified